When we applied the idea of CEBPD inactivation to RA pathogenesis, we observed that the anti-inflammatory molecules and CEBPD inhibitors inotilone and rosmanol exerted inhibitory effects on the migration and proliferation of rFLS and the tube formation of HUVECs. The gene discussed is CEBPD; the disease is rheumatoid arthritis.